Figure 2 | Scientific Reports

Figure 2

From: Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients

Figure 2The alternative text for this image may have been generated using AI.

Pathway enrichment analysis for differentially expressed genes. (a) 93 differentially expressed genes at day 0 between COVID-19 survivors and non-survivors were evaluated for enrichment of pathways. (b) 290 differentially expressed genes at day 7 between COVID-19 survivors and non-survivors were evaluated for enrichment of pathways. GeneOntology (Biological Processes), KEGG, Reactome, and Wikipathways were used in this over-representation analysis for both DEG sets. Only pathways with an adjusted p-value ≤ 0.05 for enrichment are shown.

Back to article page